2026-08-15T10:42:54-07:00 2025-12-31 LLEWELLYN LOPEZ 2129 47TH AVE SW SEATTLE WA 98116 990 2025-01-01 863335332 COLLABORATIVE COMMUNITY ON OPHTHALMIC INNOVATION FOUNDATION COLL 7034383103 11190 Sunrise Valley Dr Ste 300 Reston VA 20191 Malvina Eydelman MD CEO 2026-08-15 true Lew Lopez P01847339 2062269016 X 2025 2025-03-06 01:10:19Z 11190 Sunrise Valley Dr Ste 300 Reston VA 20191 1619910 false X https://cc-oi.org/ X 2020 DE Improve public health by advancing the diagnosis, management, and treatment of eye diseases and other medical conditions through collaboration, meetings, research initiatives, and stakeholder engagement in ophthalmic innovation. 13 12 0 15 0 160000 1482932 136674 62 304 0 160062 1619910 0 0 0 0 3829 137954 211246 137954 211246 22108 1408664 96492 1468527 26469 12276 70023 1456251 X Improve public health by advancing the diagnosis, management, and treatment of eye diseases and related conditions through collaboration across government, academia, patient groups, medical product companies, software and AI developers, and professional organizations. true true 51856 Innovation Symposium and educational convenings: The organization organized and supported educational and stakeholder convenings focused on ophthalmic innovation, including the Stanford Innovation Symposium and related meeting, webinar, registration, planning, marketing, and program-management activities. These activities promoted collaboration among government, academia, patient groups, clinicians, and industry participants. 31109 136674 FDA/BAA program: The organization continued FDA/BAA-related data-discovery and IRIS Registry analysis activities intended to advance visual health equity and real-world evidence initiatives using ophthalmic imaging and artificial intelligence. 9470 Stakeholder Council and other program services: The organization supported Stakeholder Council and related working-group activities that brought together representatives of government, academia, patient organizations, medical-product companies, software and AI developers, and professional organizations to address ophthalmic innovation priorities. 92435 true true false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false true false false false false false false false false false false false true 0 0 false 0 false false false false false false false 0 false false false false false false false X 13 12 false true true false false false false true true false false false false false false false false false VA X AIM Inc 7034383103 11190 Sunrise Valley Dr Suite 300 Reston VA 20191 X Malvina Eydelman MD CEO 10.00 0.00 X X 0 0 0 Joel Schuman MD Chairman 10.00 0.00 X X 0 0 0 Michael Abramoff MD PhD Treasurer 5.00 0.00 X X 0 0 0 David Myung MD PhD Vice President 1.00 0.00 X X 0 0 0 Mark Blumenkranz MD MMS Director 1.00 0.00 X 0 0 0 Aaron Lee MD Director 1.00 0.00 X 0 0 0 Carol Shields MD Director 1.00 0.00 X 0 0 0 Michael Repka MD Director 1.00 0.00 X 0 0 0 Emily Chew MD Director 1.00 0.00 X 0 0 0 Michelle Tarver MD PhD Director 1.00 0.00 X 0 0 0 Daniel Ting MBBS PhD Director 1.00 0.00 X 0 0 0 Flora Lum MD Director 1.00 0.00 X 0 0 0 Michael Chiang Director 1.00 0.00 X 0 0 0 Deborah O'Keefe Director 1.00 0.00 X 0 0 0 Ted Stiefel CFO 2.00 0.00 X 0 0 0 0 false false false 0 1482932 1482932 FDA BAA contract income 900099 136674 136674 136674 304 304 0 0 0 0 0 0 0 0 1619910 136978 X 0 0 0 0 0 0 0 0 0 0 10383 10383 1438 1438 15561 15561 0 0 0 56207 36791 19416 17714 6091 11009 614 320 320 3277 3277 0 0 60907 10173 50734 0 42595 39380 3215 0 0 0 1001 1001 Credit card fee 979 979 Bank Service Charges 519 519 Licenses 345 345 0 211246 92435 114982 3829 48178 837752 0 20000 423000 0 0 0 0 0 28314 207775 0 0 0 0 0 0 96492 1468527 26469 12276 26469 12276 X 70023 1456251 70023 1456251 96492 1468527 1408664 -22436 X false false false X 81000 92000 10000 160000 1482932 1825932 0 0 81000 92000 10000 160000 1482932 1825932 899460 926472 68 119 59 304 550 0 0 1826482 190874 0.50720 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED East Asia and the Pacific 0 0 Program services Ophthalmic meetings in Japan 20255 20255 20255 false false false false false false Part I, Line 3f - Method of Accounting Schedule F, Part I, line 3, column (f): The $20,255 reported for East Asia and the Pacific represents program-service expenditures, not investments, and is reported using the accrual method of accounting used in the organization's financial statements. Substantial contributor Subst. contrib. 20394 FDA/BAA consulting svc false Form 990, Part III, Line 2 During 2025, the organization expanded its exempt-purpose educational and stakeholder programming through the Stanford Innovation Symposium and related stakeholder convenings, webinars, and meeting activities, while continuing FDA/BAA-related work. Form 990, Part III, Line 3 After completing certain 2025 FDA/BAA activities, the organization placed further FDA/BAA work on hold until May 2026. The program was temporarily paused and was not terminated. Form 990, Part VI, Section A, Line 3 Association Innovation Management, Inc. provided day-to-day administrative, financial, and operational management services during part of 2025. The Board and officers retained ultimate authority over governance, budgets, programs, and major organizational decisions. Form 990, Part VI, Section A, Line 4 During 2025, the bylaws were amended to separate the President and CEO functions, transition the President role to Chairman of the Board, establish or clarify the CEO and volunteer CFO roles, and authorize compensation of the CEO. Form 990, Part VI, Section B, Line 11b The return was reviewed by the CEO, CFO, and paid preparer but was not provided to all voting members of the governing body before filing. Form 990, Part VI, Section C, Line 19 The organization did not make its governing documents, conflict-of-interest policy, or financial statements publicly available during the year, other than documents required to be made available upon request.